Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/205245
Title: Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study
Author: Ríos, A.
Rodríguez, M. A.
Puñal, J. A.
Moreno Llorente, Pablo
Mercader, E.
Ferrero, E.
Ruiz Pardo, J.
Morlán, M. A.
Martín, J.
Durán Poveda, M.
Bravo, J. M.
Casanova, D.
Salvador Egea, M. P.
Torregrosa, N. M.
Exposito Rodríguez, A.
Martínez Fernández, G.
Carrión, A. M.
Vidal Pérez, Oscar
Herrera, F.
Ruiz Merino, G.
Rodríguez, J. M.
Keywords: Càncer de tiroide
Espanya
Thyroid gland cancer
Spain
Issue Date: 17-Oct-2022
Publisher: Springer Science and Business Media LLC
Abstract: Purpose Familial papillary thyroid microcarcinoma (FPTMC) can present a more aggressive behavior than the sporadic microcarcinoma. However, few studies have analyzed this situation. The objective is to analyze the recurrence rate of FPTMC and the prognostic factors which determine that recurrence in Spain. Methods Spanish multicenter longitudinal analytical observational study was conducted. Patients with FPTMC received treatment with curative intent and presented cure criteria 6 months after treatment. Recurrence rate and disease-free survival (DFS) were analyzed. Two groups were analyzed: group A (no tumor recurrence) vs. group B (tumor recurrence). Results Ninety-four patients were analyzed. During a mean follow-up of 73.3 +/- 59.3 months, 13 recurrences of FPTMC (13.83%) were detected and mean DFS was 207.9 +/- 11.5 months. There were multifocality in 56%, bilateral thyroid involvement in 30%, and vascular invasion in 7.5%; that is to say, they are tumors with histological factors of poor prognosis in a high percentage of cases. The main risk factors for recurrence obtained in the multivariate analysis were the tumor size (OR: 2.574, 95% CI 1.210-5.473; p = 0.014) and the assessment of the risk of recurrence of the American Thyroid Association (ATA), both intermediate risk versus low risk (OR: 125, 95% CI 10.638-1000; p < 0.001) and high risk versus low risk (OR: 45.454, 95% CI 5.405-333.333; p < 0.001). Conclusion FPTMC has a recurrence rate higher than sporadic cases. Poor prognosis is mainly associated with the tumor size and the risk of recurrence of the ATA.
Note: Reproducció del document publicat a: https://doi.org/10.1007/s00423-022-02704-4
It is part of: Langenbeck's Archives of Surgery, 2022, vol. 407, num. 8, p. 3631-3642
URI: http://hdl.handle.net/2445/205245
Related resource: https://doi.org/10.1007/s00423-022-02704-4
ISSN: 1435-2451
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
s00423-022-02704-4.pdf870.74 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons